博文
双重免疫治疗为艾滋病患者带来希望：在SHIV感染恒河猴中可诱导持久缓解
||
双重免疫治疗为艾滋病患者带来希望：在SHIV感染恒河猴中可诱导持久缓解https://www.ebiotrade.com/newsf/2024-3/20240308094839885.htm
http://www.pubmedplus.cn/P/SearchQuickResult?wd=3f1f503d-b6f3-4440-a46b-83d64e24f431
| 01. | Humans | 228 篇 | 66.087% |
| 02. | HIV Infections | 211 篇 | 61.159% |
| 03. | Female | 72 篇 | 20.870% |
| 04. | Anti-HIV Agents | 57 篇 | 16.522% |
| 05. | Anti-Retroviral Agents | 51 篇 | 14.783% |
| 06. | Male | 51 篇 | 14.783% |
| 07. | Adult | 49 篇 | 14.203% |
| 08. | HIV-1 | 39 篇 | 11.304% |
| 09. | Cross-Sectional Studies | 30 篇 | 8.696% |
| 10. | Child | 24 篇 | 6.957% |
(321)
(305)
(250)
(223)
(185)
(160)
(160)
(151)
(148)
(74)
https://blog.sciencenet.cn/blog-280034-1424596.html
上一篇：生物医学科研动态 3月9日
下一篇：Nature：合成DNA揭示了不同进化阶段活细胞之间的神秘差异
